Early Detection of Alzheimer’s May be Possible Through Simple Blood Tests Investing Less invasive, early stage Alzheimer’s blood tests may be on the horizon — with big implications for future treatments of the disease.
FDA Approves Kisunla, A First-of-Its-Kind Alzheimer’s Drug SOCIETY The treatment was developed by Eli Lilly & Company and is proven to slow cognitive decline by 30%, according to press release by the Alzheimer’s Drug Discovery Foundation.
